Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Segro PLC Capital/Financing Update 2025

Feb 18, 2025

4612_rns_2025-02-18_f8639c32-dacc-4438-84cb-7b6d12001489.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

SUPPLEMENTARY PROSPECTUS DATED 14 FEBRUARY 2025

SEGRO

SEGRO plc

(Incorporated as a public limited company in England and Wales with registered office at 1 New Burlington Place, London, England, W1S 2HR with registered number 00167591)

Legal entity identifier (LEI): 213800XC35KGM9NFC641

SEGRO Capital S.à.r.l.

(a private limited liability company (société à responsabilité limitée), incorporated under the laws of the Grand Duchy of Luxembourg ("Luxembourg"), having its registered office at 35-37, avenue de la Liberté, L-1931 Luxembourg, Grand Duchy of Luxembourg and registered with the Registre de Commerce et des Sociétés, Luxembourg (the "RCS Luxembourg") under the number B256102)

Legal entity identifier (LEI): 549300HY425AKJLQVX75

£5,000,000,000

Euro Medium Term Note Programme

guaranteed (in the case of Notes issued by SEGRO Capital S.à r.l.) by

SEGRO plc

This supplement (the "Supplement", which definition shall also include all information incorporated by reference herein) to the base prospectus dated 7 June 2024 (the "Base Prospectus", which definition shall also include the base prospectus as supplemented, amended or updated from time to time, including by the supplement dated 26 July 2024, and includes all information incorporated by reference therein), which constitutes a base prospectus for the purposes of Article 8 of Regulation (EU) 2017/1129 as it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), constitutes a supplementary prospectus for the purposes of Article 23 of the UK Prospectus Regulation and is prepared in connection with the £5,000,000,000 Euro Medium Term Note Programme established by SEGRO plc (the "Company") and SEGRO Capital S.à.r.l. (each an "Issuer" and, together, the "Issuers"). Terms defined in the Base Prospectus have the same meaning when used in this Supplement.

This Supplement is supplemental to, updates, must be read in conjunction with, and forms part of, the Base Prospectus.

This Supplement has been approved by the United Kingdom Financial Conduct Authority (the "FCA"), which is the United Kingdom competent authority for the purposes of the UK Prospectus Regulation. Such approval should not be considered as an endorsement of the Issuers or the quality of the Notes that are the subject of this Supplement. Investors should make their own assessment as to the suitability of investing in any Notes. The FCA only approves this Supplement


as meeting the standards of completeness, comprehensibility and consistency imposed by the UK Prospectus Regulation.

To the extent that any document or information incorporated by reference or attached to this Supplement itself incorporates any information by reference, either expressly or impliedly, such information will not form part of this Supplement for the purposes of the UK Prospectus Regulation, except where such information or documents are stated within this Supplement as specifically being incorporated by reference or where this Supplement is specifically defined as including such information.

The Base Prospectus, this Supplement and copies of documents incorporated by reference in the Base Prospectus are available on the website of the London Stock Exchange at www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.

Each Issuer accepts responsibility for the information contained in this Supplement and declares that, to the best of their knowledge, the information contained in this Supplement is in accordance with the facts and makes no omission likely to affect its import.

Purpose of this Supplement

The purpose of this Supplement is to: (i) update the section of the Base Prospectus entitled "Documents Incorporated by Reference" beginning on page 43 of the Base Prospectus in order to incorporate a regulatory announcement of the Company published on the regulatory information service operated by the London Stock Exchange and on the Company's website at https://www.segro.com/investors relating to the Company's audited financial and operating performance between 1 January and 31 December 2024, and (ii) update the "Significant or Material Change" statement on page 148 of the Base Prospectus accordingly.

Updates to Documents Incorporated by Reference

In the section of the Base Prospectus entitled "Documents Incorporated by Reference", the following paragraph shall be added on page 44 as a new paragraph (iv):

(iv) the announcement of the Company dated 14 February 2025 relating to the Company's audited financial and operating performance for the year ended 31 December 2024 (the "2024 Full-year Results"),

(which can be accessed at https://www.segro.com/media/lzedfxwv/fy-2024-press-release-full-version-final.pdf)

Significant or Material Change

The section entitled "Significant or Material Change" on page 148 of the Base Prospectus shall be deemed to be deleted and replaced with the following:

"There has been no significant change in the financial performance or position of the Company or the Group since 31 December 2024. There has been no material adverse change in the financial position or prospects of the Company or the Group since 31 December 2024.


There has been no significant change in the financial performance or financial position of SEGRO Capital since 31 December 2024. There has been no material adverse change in the prospects of SEGRO Capital since 31 December 2024."

General

To the extent that there is any inconsistency between: (a) any statement in this Supplement or any statement incorporated by reference into this Supplement and (b) any other statement in or incorporated by reference into the Base Prospectus, the statements in (a) above will prevail.

Save as disclosed in this Supplement, there has been no significant new factor, material mistake or inaccuracy relating to information included in the Base Prospectus since the publication of the Base Prospectus.

3